MICHELLE ZANANIRI: Open Payments
NPI 1124460589 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 50 payments from 13 companies in 2025. Trend: 2023 $775 · 2024 $988 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $254 |
| ABBVIE INC. | 11 | $212 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Lilly USA, LLC | 4 | $76 |
| Astellas Pharma US Inc | 3 | $75 |
| Biogen, Inc. | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Novo Nordisk Inc | 2 | $39 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $20 |
Products named: QULIPTA, NURTEC ODT, PREVNAR 20, Veozah, MOUNJARO, SKYCLARYS, VRAYLAR, ELIQUIS.
Industry payments across VA — which companies pay providers there.
